I took the opportunity to look back on the 1H19 results and something did not quite add up: guidance was upped from revenues 82-88 million to 88-94 million, yet ebtda range was only tightened rather than upped as well. 1h revenue was 47 million and 2h will at least equal 1h. so this means an additional 6 million of revenues at zero margin? watch out above - there's an upgrade coming
- Forums
- ASX - By Stock
- potential for near term upgrade
I took the opportunity to look back on the 1H19 results and...
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
91.8¢ |
Change
0.008(0.82%) |
Mkt cap ! $343.2M |
Open | High | Low | Value | Volume |
92.0¢ | 93.0¢ | 91.5¢ | $160.4K | 173.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 34511 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 11520 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 35718 | 0.915 |
15 | 56381 | 0.910 |
9 | 219018 | 0.905 |
8 | 88525 | 0.900 |
7 | 47658 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 11520 | 11 |
0.925 | 35240 | 11 |
0.930 | 26435 | 10 |
0.935 | 41533 | 9 |
0.940 | 34083 | 9 |
Last trade - 11.28am 03/07/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online